当前位置:首页 - 行情中心 - 新芝生物(430685) - 财务分析

新芝生物

(430685)

  

流通市值:4.96亿  总市值:10.18亿
流通股本:4458.44万   总股本:9151.60万

新芝生物(430685)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2024年第一季度实现净利润0.03亿元,每股收益0.03元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2024年第一季度最新股东权益56959.31万元,未分配利润9134.31万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2024年第一季度最新总资产62582.32万元,负债5623.00万元。

利润表
报告期2024-03-312023-12-312023-09-302023-06-30
营业总收入27,428,266.45190,794,145.37131,282,869.588,018,599.76
营业总成本25,910,739.5138,960,711.3796,371,658.1663,501,989.35
营业利润4,000,769.6965,299,516.3845,064,707.2331,661,499.6
利润总额3,741,649.876,480,128.2956,509,455.9643,124,285.07
净利润3,132,087.5666,916,868.9643,049,386.2132,600,227.09
其他综合收益----
综合收益总额3,132,087.5666,916,868.9643,049,386.2132,600,227.09
资产负债表
报告期2024-03-312023-12-312023-09-302023-06-30
流动资产合计485,042,394.82500,099,224.08500,805,461.91505,850,631.8
非流动资产合计140,780,777.82111,143,790.8885,350,017.6484,367,370
资产总计625,823,172.64611,243,014.96586,155,479.55590,218,001.8
流动负债合计54,729,556.7542,485,404.2545,731,740.8140,742,262.62
非流动负债合计1,500,472.332,236,392.693,194,842.954,100,443.4
负债合计56,230,029.0844,721,796.9448,926,583.7644,842,706.02
归属于母公司股东权益合计540,259,608.84537,516,373.97513,461,187.3523,156,357.68
股东权益合计569,593,143.56566,521,218.02537,228,895.79545,375,295.78
负债和股东权益合计625,823,172.64611,243,014.96586,155,479.55590,218,001.8
现金流量表
报告期2024-03-312023-12-312023-09-302023-06-30
经营活动现金流入小计40,042,350.09235,141,531.69169,204,016.49118,403,826.38
经营活动现金流出小计49,990,082.64178,900,439.8136,255,600.5399,096,377.75
经营活动产生的现金流量净额-9,947,732.5556,241,091.8932,948,415.9619,307,448.63
投资活动现金流入小计257,540,721.48899,320,281.43599,155,622.67302,158,571.65
投资活动现金流出小计215,953,464.91,231,837,128.32863,890,391.87594,485,179.87
投资活动产生的现金流量净额41,587,256.58-332,516,846.89-264,734,769.2-292,326,608.22
筹资活动现金流入小计-2,000,000--
筹资活动现金流出小计1,325,420.5993,817,056.291,414,268.6771,362,168.89
筹资活动产生的现金流量净额-1,325,420.59-91,817,056.2-91,414,268.67-71,362,168.89
汇率变动对现金及现金等价物的影响24,210.3726,546.5539,983.3730,657.27
现金及现金等价物净增加额30,338,313.81-368,066,264.65-323,160,638.54-344,350,671.21
期末现金及现金等价物余额157,926,574.6127,588,260.78172,493,886.89151,303,854.22
TOP↑